Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Poor Outcome of Generalized Peritonitis linked to Enterococcus Species and Yeasts

By HospiMedica International staff writers
Posted on 31 Jul 2009
A new study has found that the detection of Enterococcus species and yeasts in peritoneal fluid can be associated with poor outcomes in patients with secondary generalized peritonitis.

Researchers at Hôpital Lariboisière (Paris, France) prospectively compared the outcomes of 180 consecutive adult patients with community-acquired or postoperative peritonitis who were seen at the medical center over a six-year period; secondary generalized peritonitis was surgically confirmed in all cases. More...
The frequency of septic shock was 41% and the overall mortality rate was 19%; among those who developed septic shock, the mortality was 35%, compared with 8% among patients who did not develop septic shock. The researchers then investigated the factors that predicted septic shock and mortality in these patients.

The researchers found that mortality was not different between patients with community-acquired and postoperative peritonitis, a finding that is counter to some previous published reports, which have typically found that postoperative peritonitis is the more severe type. Other risk factors for septic shock included age of more than 65 years, detection of two or more microorganisms in the peritoneal fluid, and anaerobes in peritoneal fluid. Among patients with septic shock, biliary origin was also associated with increased mortality. However, detection of intraperitoneal yeasts and Enterococci were associated with septic shock in community-acquired peritonitis, and yeasts in the peritoneal fluid of patients with postoperative peritonitis and septic shock were an independent risk factor for death. The study was published on June 24, 2009, in the online edition of Critical Care.

"The outcomes of patients with postoperative and community-acquired peritonitis may have depended more on management than on the pathophysiological process,” said lead author Bernard Cholley, M.D., of the department of anesthesiology and intensive care. "These findings reinforce the need for prospective trials evaluating systemic treatment against these microorganisms in patients with secondary peritonitis.”

The researchers noted that although it is generally accepted that the prognosis for postoperative peritonitis is worse than for community-acquired peritonitis, the data on which this notion is based are rather frail. For example, the time elapsed between peritoneal contamination and surgery, which is very difficult to measure precisely, may actually be longer for postoperative peritonitis than for community-acquired peritonitis, which is usually operated on soon after admission.

Related Links:
Hôpital Lariboisière




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.